INTRODUCTION
Maintenance of glucose levels is of great physiologic importance, and imbalances lead to an array of detrimental effects. Reduced glucose levels cause symptoms ranging from mild discomfort to severe confusion, seizures, and ultimately, brain damage (Agrawal et al., 2014) . At the cellular level, glucose is mostly utilized as an energy source and is also required for protein glycosylation, which serves a variety of structural and functional roles in membrane-bound and secreted proteins. Glycosylation is a major form of protein modification in eukaryotes. It has been estimated that approximately half of all human proteins are glycosylated and most contain N-glycan structures (Apweiler et al., 1999) . High-mannose-type N-glycans are reported to constitute approximately 40% of all N-glycans in mouse brains (Ishii et al., 2007) . Furthermore, it is well known that N-glycosylation improves protein stability and regulates the function of cytokines and chemokines (Opdenakker et al., 1995) . Hence, protein glycosylation plays very important roles for protein homeostasis and function.
Sugar insufficiency is one of the leading causes of endoplasmic reticulum (ER) stress. Cells cope with ER stress via three types of ER stress sensors and respond by deploying the unfolded protein response (UPR). The sensors are PKR-like ER kinase (PERK), inositol-requiring enzyme 1a (IRE1a), and activating transcription factor 6 (ATF6). Following the activation of these sensors, different signaling nodes, such as c-Jun N-terminal kinase 1, and downstream transcription factors, such as X-box-binding protein 1 (XBP1), activating transcription factor 4 (ATF4), and C/EBP homologous protein (CHOP), are activated (Mori, 2009) . For example, IRE1a is activated by self-phosphorylation and manifests endoribonuclease activity, which cleaves a cryptic 26-bp exon from the downstream target XBP1 mRNA. The resulting unconventionally spliced mRNA encodes an alternate XBP1 protein, spliced XBP1 (XBP1s), which is a highly active transcription factor that promotes the expression of ER chaperones and molecules involved in ER-associated degradation (Yoshida et al., 2001) . Notably, XBP1s-dependent activation of the hexosamine biosynthetic pathway (HBP), which converts glucose to uridine 5 0 -diphosphate N-acetylglucosamine (UDP-GlcNAc) for N-and O-glycosylation of proteins, has been reported to protect cells from various biological insults, such as ER stress and cardiac ischemia/reperfusion injury (Wang et al., 2014) . Hence, XBP1s is particularly important for cell survival.
Most studies of mammalian sugar metabolism concentrate on glucose, owing to its central roles in not only energy generation but also protein glycosylation. Other hexoses, e.g., mannose and galactose, receive relatively little attention in metabolic and physiologic studies. Mannose is a C2 epimer of glucose and is naturally found in microbes, plants, and animals. Free mannose is found in mammalian plasma at 50-100 mM (Alton et al., 1998). Galactose is a C4 epimer of glucose. Galactose, which is of particular relevance to mammals, is mostly produced by hydrolysis of the milk sugar lactose, a disaccharide with a glycosidic linkage between glucose and galactose. Free galactose concentrations in plasma are usually <10 mg/dL (0.56 mM) (Kaempf et al., 1988) . The detectable plasma galactose levels in normal adult humans suggest that the dietary acquisition of modest amounts of galactose from fruits and vegetables, e.g., tomatoes, bell peppers, brussels sprouts, apples, bananas, persimmons, dates, etc., (Gross and Acosta, 1991) is beneficial. Galactose is metabolized by the enzymes of the Leloir pathway in the liver (Frey, 1996) , which requires several enzymes to convert galactose to glucose-6-phosphate (G6P). In mammals, mutations in some of these enzymes can result in the genetic disease galactosemia (Leslie, 2003; Holden et al., 2004; Timson, 2006) . Despite such disadvantageous features of galactose, mammals must use galactose for something important, because lactose, the milk sugar, consists of galactose and glucose as a heterodimer. Based on the evidence that lactose is an essential nutrient for mammalian babies, one of the biggest and long-lasting questions in biology has been why galactose has been evolutionally selected as a major component of lactose.
RESULTS

Galactose Promotes N-Glycosylation Preferentially over Glucose or Mannose
Sugar deprivation induces immature N-GlcNAc 2 -modified glycoproteins, which cross-react with the O-GlcNAc-specific antibody CTD110.6 (Isono, 2011) . We also independently observed that HEK293 cells produced proteins recognized by CTD110.6 antibody under sugar deprivation and that ER stress was evident under this condition ( Figure 1A ). We successfully identified laminin g1 and laminin b2 as CTD110.6-antibody-recognized proteins, by immunoprecipitation with CTD110.6 antibody, followed by liquid chromatography-tandem mass spectrometry analyses (Figures S1A and S1B). Both of these are N-linked high-mannose-type glycoproteins (Fujiwara et al., 1998) . Indeed, CTD110.6 antibody recognized only lower-molecular-weight or immature forms of laminin g1 and laminin b2, which appeared only upon sugar starvation. We also showed that an anti-laminin g1 antibody revealed aggregate-like structures in cells under sugar starvation, most likely in the ER (Ikeda et al., 2014) . Pulse-chase experiments using [ 35 S] methionine/cysteine indicated that N-GlcNAc 2 -modified laminin b2 was a newly synthesized protein rather than a cleavage product of mature N-glycosylated laminin b2 ( Figure S2 ). Addition of varying amounts of glucose in a dose-and time-dependent manner eliminated these immature glycoproteins and ER stress ( Figures 1B and S1C ). These results clearly indicated that sugar-deprivation-induced ER stress is correlated with the accumulation of immature glycoproteins in the ER.
To elucidate the role of other hexoses in protein glycosylation, we then focused on mannose and galactose and examined how these sugars function in producing mature N-glycosylated proteins, when compared with glucose. Mannose showed an essentially identical capacity as glucose with regard to the production of mature N-glycosylated proteins and the reduction of ER stress ( Figure 1C ). Surprisingly, however, galactose was 10 times more effective at producing mature N-glycosylated proteins and canceling ER stress ( Figure 1D ). In other words, 0.3 mM galactose was just as effective as 3 mM glucose or 3 mM mannose in the production of mature N-glycosylated proteins and abatement of ER stress ( Figures 1B-1E ). Furthermore, both 0.3 mM galactose ( Figure 1F ) and 3 mM glucose ( Figure S1C ) led to mature laminin g1 production over a similar time course. We also observed that galactose had the same robust ability to produce mature N-glycosylated proteins and to reduce ER stress in other cell lines, including human hepatoblastoma-derived HepG2 cells and rat pheochromocytoma-derived PC12 cells ( Figure S3 ).
Sugar Deprivation Increases the Expression of Enzymes Involved in N-Glycosylation via XBP1s
Activated nucleotide sugars, such as UDP-GlcNAc and guanosine diphosphate mannose (GDP-Man), which are required for N-glycosylation, are derived from fructose-6-phosphate (F6P) (Dennis et al., 2009) . We therefore speculated that cellular mechanisms should exist to compensate for the glycosylation failure under sugar deprivation. Based on such speculation, we performed qRT-PCR analyses on mRNAs of glycolytic pathway enzymes and observed the upregulation of HK2, ALDO, and ENO4 mRNAs in response to sugar deprivation ( Figure 2A ). We also observed upregulation of mRNAs for GFAT1 and GMPP (A and B), which are responsible for the production of UDP-GlcNAc and GDP-Man, respectively (Figures 2B and 2C) (Dennis et al., 2009; Szumilo et al., 1993; Ning and Elbein, 2000) . mRNA for STT3A, but not for STT3B, both of which encode catalytic subunits of the N-oligosaccharyltransferase (OST) complex (Kelleher et al., 2003; Ruiz-Canada et al., 2009) , was also upregulated ( Figure 2C ). Protein levels of HK2, GFAT1, GMPPA, and GMPPB were also increased by sugar deprivation ( Figure S4 ). Subsequently, we tested whether other ER stress inducers, e.g., thapsigargin and brefeldin A, produced similar effects and found that HK2, GFAT1, GMPPA, GMPPB, and STT3A mRNAs and the corresponding proteins increased ( Figure S5 ).
Under ER stress, ATF4, ATF6, and XBP1 function as transcription factors to upregulate their target genes to cope with the ER-stress-inducing conditions; the induction of these specific target mRNAs constitutes part of the UPR (Walter and Ron, 2011). We examined whether overexpression of these transcription factors would alter the expression of the same genes that were upregulated during sugar deprivation. We found that overexpression of the ER-stress-related XBP1s led to increases in transcription of all the abovementioned genes that were upregulated during sugar deprivation ( Figure 2D) ; overexpression of ATF4, but not ATF6, just slightly increased the abundance of HK2 and GFAT1 mRNAs ( Figure 2D ). Overexpression of ATF4 or ATF6 increased the expression of XBP1 mRNA in the glucose(+) condition (Figures S6A and S6B) (Yoshida et al., 2001; Tsuru et al., 2016) . However, overexpression of ATF4, but not ATF6, induced IRE1a protein ( Figure S6C ), and the former, but not the latter, marginally induced the unconventional splicing (E) Quantitative analysis of reactivity with CTD110.6 antibody in (B-D), normalized to actin intensity. The value for the sugar-free condition was set as 1. The data are the mean G SEM (n = 3). *p < 0.05, **p < 0.01, ***p < 0.005 by Dunnett's test.
(F) HEK293 cells were pre-treated with sugar-free medium for 24 hr followed by re-feeding 0.3 mM galactose for indicated times. Actin was monitored as a loading control. Cells were cultured under serum-free conditions. See also Figures S1-S3.
that generated XBP1s mRNA, albeit very weakly ( Figure S6D ) (Tsuru et al., 2016) . The XBP1 splicing appeared to occur without inducing conspicuous IRE1a phosphorylation. This observation may be explained as follows: the increased IRE1a protein might weekly oligomerize by itself and induce self-phosphorylation, but the phosphorylation levels were very weak and below the detection levels of the antibody used. Overexpression of XBP1s, but not ATF4 or ATF6, clearly upregulated the protein levels of N-glycosylationrelated genes, except for STT3A ( Figure 2E ). We also found that XBP1 knockdown significantly diminished the upregulation of the N-glycosylation-related mRNAs in response to sugar deprivation ( Figure 2F ). Furthermore, XBP1s production, induced by sugar deprivation, was inhibited by the addition of galactose in a dose-dependent manner ( Figure 2G ). Consistent with these results, the addition of a trace amount of galactose dose dependently suppressed the upregulation of the N-glycosylation-related mRNAs that were induced by sugar deprivation ( Figure 2H ).
Accumulation of F6P in Galactose(+) Condition
We then questioned whether added galactose is metabolized via the Leloir pathway to activated nucleotide sugars and is used in the mature N-glycosylated proteins, such as laminin b2. We then observed that [ 14 C]galactose was indeed incorporated in mature laminin b2 ( Figure 3A) , demonstrating that the added galactose is incorporated as a carbon source into sugar chains of laminin b2.
We next measured the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR). Glucose or mannose immediately increased ECAR, leading to a compensatory decrease of OCR. In contrast, galactose did not alter ECAR or OCR at all ( Figure 3B ). Rotenone, a complex I inhibitor, decreased OCR with all indicated sugar conditions. Decreased OCR induced a compensatory increase of ECAR in glucose(+) or mannose(+) medium, but not in galactose(+) medium ( Figure 3B ).
Given that galactose did not affect ECAR despite entering the glycolytic pathway, we expected that in the galactose(+) medium the glycolytic pathway may arrest, and then the corresponding metabolites would accumulate somewhere within the glycolytic pathway. We therefore performed a metabolome analysis with capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS) to evaluate metabolite levels in HEK293 cells treated with sugar-free, 3 mM glucose, and 3 mM galactose for 6 hr ( Figure 3C ). In the sugar-free condition, levels of metabolites just upstream of dihydroxyacetone phosphate (DHAP) were essentially undetectable, e.g., glucose-1-phosphate (G1P), G6P, F6P, and fructose-1, 6-bisphosphate (Figure 3C ). In the glucose(+) condition, the metabolites upstream of F6P appeared to be rapidly metabolized in the glycolytic pathway ( Figure 3C ). By contrast, in the galactose(+) condition, metabolite levels upstream of F6P dramatically increased, when compared with the sugar-free and the glucose(+) conditions. Consistent with the results of flux analyses ( Figure 3B ), in the galactose(+) condition, the amount of lactic acid, which reflects the ECAR, was comparable to that in the sugar-free condition, and was much lower than the amount of lactic acid in the glucose(+) condition ( Figure 3C ).
The level of UDP-GlcNAc even in the sugar-free condition was similar to those in the other two conditions ( Figure 3C ), and cells cultured in the sugar-free condition for a much longer time (e.g., 72 hours) retained the N-GlcNAc 2 modifications ( Figure S7A ), indicating that UDP-GlcNAc is mostly supplied by its re-usage Immunoprecipitates with His antibody were analyzed by silver staining, western blot, and autoradiography.
in the cells (Rome and Hill, 1986) , but not by HBP. Consistently, cells cultured with azaserine or 6-diazo-5-oxo-1-norleucine, both of which are HBP inhibitors, were unaffected with regard to the maturation of N-glycosylated proteins or the abatement of ER stress in the presence of glucose or galactose ( Figure S7B ). These results further support the idea that accumulated F6P in the galactose(+) condition is preferentially utilized to produce GDP-Man for the maturation of high-mannose-type glycoproteins. It is notable that addition of bafilomycin A1 or E64d/pepstatin A, each of which is an inhibitor of autophagy, did not affect the maturation of N-glycosylated proteins by galactose ( Figure S7C ). These results appear to rule out the involvement of autophagy in the maturation of N-glycosylated proteins by galactose.
We next investigated whether galactose affects the expression level of phosphofructokinase 1 (PFK1), but the expression levels of PFK1 in the HEK293 cells were almost identical among all conditions ( Figure 3D ). We then compared PFK1 activity among the conditions. Interestingly, we found that PFK1 activity increased in parallel with the glucose concentrations of culture medium, and galactose was unable to activate PFK1 ( Figures 3E  and 3F ). On the other hand, the PFK1 activity was not inhibited by the addition of galactose or galactose metabolites, e.g., galactose-1-phosphate and UDP galactose ( Figure 3G ). Taken together, these results indicate that galactose does not stimulate the PFK1 activity, leading to the accumulation of galactose-derived F6P.
A Trace Amount of Galactose Reduces ER Stress and Cell Death in Sugar Deprivation
Next, we investigated the effects of glucose or galactose on the prevention of cell death induced by sugar deprivation. Supplementation with 3 and 25 mM glucose increased cell proliferation in a dose-dependent manner ( Figure 4A ). However, 0.3 mM glucose showed no effect on cell proliferation or protection, when compared with the sugar-free condition. In contrast, 0.3 mM galactose dramatically induced cell proliferation. With 3 mM galactose, cell proliferation slightly decreased, compared with 3 mM glucose or 0.3 mM galactose. These observations may reflect a condition of patients with galactosemia, having a milieu of symptoms including cataracts, liver, and brain growth failure (Lai et al., 2009) .
A Trace Amount of Galactose Promotes Growth Signal Transduction via the Maturation of Protein Glycosylation
Based on the evidence that many growth factors and their receptors are glycoproteins (Takahashi et al., 2004; Kaszuba et al., 2015) , we examined the protein status of growth factor receptors, such as epidermal growth factor (EGF) receptor (EGFR) and insulin growth factor (IGF) receptor (IGFR). In the sugar-starved conditions, maturation of EGFR was clearly inhibited, and protein levels of IGF1Rb were greatly reduced ( Figure 4B ). Mature and immature EGFR and IGF1Rb were mainly detected in the membrane fraction (Figures 4C-4E ). However, in the starved condition, responses of cells to EGF, IGF, and serum were reduced, which was evidenced by the absence of ERK phosphorylation ( Figures 4F-4H ). Addition of a trace amount of galactose, namely, 0.3 mM galactose, was able to correct these abnormalities. By contrast, these abnormalities were not corrected by the addition of 0.3 mM glucose ( Figures 4F-4H ).
DISCUSSION
Animals must overcome various environmental challenges. Among them, starvation might be common but most dangerous, and thus animals should be equipped to cope with such potentially fatal conditions. Starvation, especially sugar deprivation, has been known to induce ER stress, which is evidenced by the (E) HEK293 cells were treated with the indicated conditions for 6 hr, and PFK1 activity was analyzed by measuring NADH consumption.
(F) HEK293 cells were sugar-deprived (SD) for 6 hr, followed by restoration with the indicated sugars (3 mM each) for 1 hr.
(G) HEK293 cells were cultured in medium containing glucose (3 mM) for 6 hr, and PFK1 activity was analyzed in a reaction mixture that included galactose (Gal) (3 mM), galactose-1-phosphate (Gal-1P) (3 mM), or UDP galactose (UDP-Gal) (3 mM). The data are the mean G SEM. ***p < 0.005 by Dunnett's test. Cells were cultured under serum-free conditions. See also Figure S7 . induction of CHOP and GRP78 proteins. In this study, we observed the production of immature glycosylation forms of high-mannose-type glycoproteins, which were recognized by CTD110.6 antibody in sugar-starved cultured cells (Isono, 2011) . Given that levels of GDP-Man decrease under sugar starvation, and that the molecule recognized by CTD110.6 antibody is N-GlcNAc 2 (Isono, 2011) , addition of mannose to dolichol-pyrophosphate-GlcNAc 2 (Dol-PP-GlcNAc 2 ) by b-1,4 mannosyltransferase-1 (ALG1) (Couto et al., 1984) would not occur. Thus ALG1 functions as the sensor to monitor the levels of GDP-Man in the cells; when the levels of GDP-Man become much lower than the KD value, any addition of mannose to Dol-PP-GlcNAc 2 would cease. In this scenario, mammalian cells utilize such naked Dol-PP-GlcNAc 2 , instead of mature glycans, as the substrate of OST to produce immature glycoproteins. As the presence of such immature glycoproteins appeared to be intimately coupled with the evocation of ER stress, cells appear to engage a system to induce an ER stress response via the production of immature glycoproteins under starvation. Consistently, we were able to show that ER stress leads to the expression of HK2, GFAT1, and GMPP, essential enzymes involved in the synthesis of N-glycosylation components (e.g., UDP-GlcNAc, GDP-Man), and that XBP1s is responsible for their expression. It is noteworthy that UDP-GlcNAc and GDPMan are also utilized in O-glycosylation (Spiro, 2002) . Therefore, it is also expected that maturation of not only N-glycosylated but also O-glycosylated proteins is also hindered under sugar starvation and that maturation of both N-and O-glycosylated proteins is also restored by a trace amount of galactose.
Other ER stress inducers, e.g., thapsigargin and brefeldin A, which are not related to the production of immature glycoproteins, also induce HK2, GFAT1, GMPPA, GMPPB, and STT3A mRNAs and the corresponding proteins, indicating that the response to immature glycoproteins is a fundamental, perhaps archetypical ER stress response.
We demonstrated that galactose is much more potent to maintain mature N-glycosylation of proteins than glucose and mannose. Maintenance of mature N-glycosylation contributes to the relief of starvationinduced ER stress and cell death and also to appropriate growth-factor-mediated signal transduction. From our metabolome data, under the galactose(+) condition accumulation of galactose-derived F6P was observed, which would be utilized in the production of nucleotide sugars required for N-glycosylation. However, such F6P accumulation was not observed in the glucose(+) condition. It is notable that galactose itself is utilized in other types of glycosylation. These observations indicate that galactose from milk or milk sugar would preferentially contribute to produce mature glycoproteins rather than to energy production during starvation. It is obvious that malnutrition affects the growth of infants. Furthermore, it has been shown that newborn babies experience what can be considered to be seriously starved conditions at birth (Burns et al., 2008; Adamkin and Committee on Fetus and Newborn, 2011) , and that to survive these conditions, autophagy and milk play crucially important roles for the supply of nutrients as energy sources (Kuma et al., 2004) . Our results indicate that milk, as a sugar source, is also necessary for the maturation of glycoproteins, which in turn contribute not only to the prevention of ER stress and cell death in many organs but also to the maintenance of growth-factor-mediated signaling for the normal post-natal growth of infants.
Limitations of the Study
The study was conducted only in cultured mammalian cells. Therefore, for the substantiation of the beneficial functions of galactose during starvation in vivo, it will be necessary to perform animal experiments, examining both cellular and overall responses under similar conditions.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. 
SUPPLEMENTAL INFORMATION
DECLARATION OF INTERESTS
The authors declare no competing interests. Expression levels of proteins related to sugar-free upregulated mRNA levels (see Figures 2A-2C ) were analyzed by western blotting using the indicated antibodies (left panels). Cells were cultured under serum-free conditions. Quantitative analysis of the protein levels normalized to actin is shown (right panels). The data are the mean ± SEM (n = 3). * P < 0.05, ** P < 0.01 by Student's t test. Quantitative analysis of protein levels normalized to actin is shown (right panels). The data are the mean ± SEM (n = 3). * P < 0.05, ** P < 0.01 by Dunnett's test (vs. Cont.). 
Name of Primer sequence (5' -3')
EcoRI-mATF4-F cggaattccATGACCGAGATGAGCTTCCTGAACAGC mATF4-XbaI-R gctctagaTTACGGAACTCTCTTCTTCCCCCTTGCC ClaI-mATF6-F ccatcgatcATGGTGGTGGTGGCAGCGGCGCCGAGC mATF6-Asp718I-R gctctagaTTAGACACTAATCAGCTGGGGGAAAAG ClaI-mXBP1s-F ccatcgatcATGGTGGTGGTGGCAGCGGCGCCGAGC mXBP1s-XbaI-R gctctagaTTAGACACTAATCAGCTGGGGGAAAAG 
Construction of Expression Vectors
Mouse full-length ATF4, ATF6, and spliced XBP1 (XBP1s) were amplified from cDNA from B16F10 cells using the indicated primers (see Table S1 ), and subcloned into EcoRI-XbaI sites, ClaI-Asp718I sites, and ClaI-XbaI sites of the pFLAG-CMV2
vector, respectively. C-terminal 6×His-tagged rat Laminin β2 was obtained by subcloning the cDNA insert into the pcDNA3-6×His vector.
Reagents
D-glucose, D-mannose, D-galactose, L-glutamine, sodium pyruvate, and 2-deoxy-Dglucose (2-DG) were purchased from Nacalai Tesque. Thapsigargin (Tg) was obtained from WAKO. Rotenone, oligomycin, bafilomycin A1, E64d, pepstatin A, and UDPGalactose (UDP-Gal) were purchased from Sigma-Aldrich. Brefeldin A (BFA) and galactose-1-phosphate (Gal-1P) were obtained from Millipore. Azaserine (AZA) and 6-diazo-5-oxo-1-norleucine (DON) were purchased from Santa Cruz Biotechnology.
Western Blotting
Cells were lysed in RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, 0.1% SDS, 25 mM Tris-HCl, pH 7.6) containing a protease inhibitor cocktail (Roche), sonicated, and centrifuged at 15,000 ×g for 10 min. The protein content of supernatants was quantified using a BCA assay kit (Nacalai Tesque). Proteins
LC-MS/MS Analysis and Identification of N-GlcNAc2 Modified Proteins
To identify the CTD110.6-interacting bands, gels were silver-stained using Sil-Best Stain One (Nacalai Tesque) and immunoblotted with CTD110.6 antibody. Each identified band was digested in the gel by modified trypsin (Promega). The extracted samples were analyzed by LC-MS/MS using an LTQ mass spectrometer (Thermo Fisher Scientific) combined with Paradigm MS4 HPLC (Michrom BioResources). Both MS and MS/MS spectra were searched against the Mascot database (Matrix Science) to identify the proteins.
RT-qPCR
Total RNA was isolated from cells using the SV total RNA isolation kit (Promega). For cDNA synthesis, total RNA (1 μg) was reverse transcribed using ReverTra Ace qPCR RT Master Mix with gDNA Remover (TOYOBO), according to the manufacturer's protocol. qPCR was performed on a LightCycler PCR System (Roche Diagnostics) and carried out at 98ºC for an initial 2 min followed by 45 cycles of denaturation at 98ºC for 10 sec, annealing at 60ºC for 10 sec, and extension at 68ºC for 30 sec using KOD SYBR qPCR Mix (TOYOBO). Primer sets are listed in Table S2 . Primers were designed and selected with the use of LightCycler Probe Design software 2.0 (Roche Applied Bioscience). The GAPDH was used as an internal control for normalization of target gene expression.
XBP1 splicing assay
To assess the variant XBP1 by PCR, sequence of the primers were used as same as qPCR, corresponding to nucleotides 428-449 and 689-710 of the human XBP1 cDNA generating two PCR products of 283 (unspliced XBP1, XBP1u) and 257 (spliced XBP1, XBP1s) base pairs. Cycling condition was carried out at 95ºC for an initial 30 sec followed by 28 cycles of denaturation at 95ºC for 10 sec, annealing at 60ºC for 10 sec and extension at 72ºC for 5 sec using PrimeSTAR Max DNA polymerase (TaKaRa).
The PCR products were separated on a polyaclylamide gel. The GAPDH was used as an internal control.
RNA Interference
siRNAs for PERK (s18102), IRE1 (s200430), ATF6 (s22688), and XBP1 (s14913) were obtained from Ambion (LifeTechnologies) using the Silencer Select siRNA series.
Target siRNA or control siRNA (Silencer Select Negative Control No.1 siRNA;
Ambion) was transfected into HEK293 cells using Oligofectamine (Invitrogen) in each well of 6-well plates following the manufacturer's instructions. The cells were cultured for 72 h prior to use in the knockdown experiments. .
ECAR and OCR Measurements
ECAR and OCR were measured using the Seahorse XF96 Flux Analyzer in accordance with the manufacturer's instructions (Seahorse Bioscience, USA). The XF96 microplate was coated with type I collagen (Nitta Gelatin) and left for at least 1 h at room temperature. Briefly, cells were seeded in a microplate in the corresponding cell growth medium and then incubated at 37ºC in 5% CO2 for 24 h. Before changing the assay medium, cells were exposed to sugar-free conditions for 3 h. Assays were initiated by replacing the medium with 175 μL assay medium supplemented with 4 mM glutamine and without sugars. The microplates were incubated at 37ºC for 2 h to equilibrate the temperature and pH of the media before measurement. After incubation, the plate was loaded on the analyzer. The concentrations of compounds sequentially added to the medium (175 μL) of the cell plate during the course of the experiment were 24 mM sugar, 27 μM rotenone, and 1 M 2-DG in volumes of 25 μL each, resulting in final concentrations of 3 mM sugar, 3 μM rotenone, and 100 mM 2-DG, respectively. The final injection was 2-DG, a glucose analog, which inhibits glycolysis through competitive binding to glucose hexokinase, the first enzyme in the glycolytic pathway.
All values of ECAR and OCR were normalized to cell number. Data shown are the representative mean ± SEM from three independent experiments.
Carbon-14 Labeling Study
D-[1-14 C]galactose (PerkinElmer) was used for labeling sugar chains on 6×His-tagged Laminin β2. Cells transfected with mock or a 6×His-tagged Laminin β2 expression construct were plated in 6-well plates, and maintained for 24 h. When cells were 100% confluent, the medium was changed to sugar-free medium or 0.3 mM [1-14 C]galactose medium for 24 h. After cells were harvested and lysed, 6×His-tagged Laminin β2 was pulled down using a His-tagged Protein PURIFICATION KIT (MBL), followed by SDS-PAGE and autoradiography. Detection of the labeled Laminin β2 by autoradiography was performed using an FLA7000 image analyzer (Fujifilm).
Metabolomic Analysis
HEK293 cells were seeded in three 10 cm dishes and incubated in growth media until they reached 90% confluence, then treated with medium that was sugar-free, or supplemented with 3 mM glucose or 3 mM galactose, for 6 h. The respective media were removed from the plates, and cells were washed twice with 5% mannitol solution (10 mL first and then 2 mL), treated with 800 μL of methanol (WAKO), and let stand for 30 sec. The cell extract was then treated with 550 μL of Milli-Q water containing internal standards (Human Metabolome Technologies (HMT)) and let stand for another 30 sec. The extract was obtained and centrifuged at 2,300 ×g and 4ºC for 5 min, and then 800 μL of the upper aqueous layer was centrifugally filtered through a Millipore 5-kDa cutoff filter (UltrafreeMC-PLHCC, HMT) to remove macromolecules (9,100 ×g, 4ºC, 120 min). The filtrate was centrifugally concentrated and resuspended in 50 μL of Milli-Q water for metabolome analysis at HMT and analyzed by a CE-TOFMS system (Agilent Technologies). Signal peaks were annotated according to the HMT metabolite database based on their m/z values with the migration times. Detected metabolites were plotted on metabolic pathway maps using VANTED software.
Spectrophotometric PFK1 Activity Assay
PFK1 activity was measured with slight modifications to the described procedure (Deng et al., 2008) . Cells were washed with 1 × PBS, pH 7.4, and incubated in lysis buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 0.5 mM DTT, protease inhibitor cocktail) for 10 min on ice. Briefly, the assay was performed by adding 5 μg cell lysate to 100 μL of reaction buffer containing 50 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl2, 1 mM ATP, 0.2 mM NADH (Nacalai Tesque), 5 mM Na2HPO4, 0.1 mM AMP, 1 mM NH4Cl, 5 mM fructose-6-phosphate, 5 units/mL of triose phosphate isomerase (Sigma-Aldrich), 1 unit/mL of aldolase (Sigma-Aldrich), and 1 unit/mL of α-glycerophosphate dehydrogenase (Sigma-Aldrich). The mixture was incubated at room temperature, and absorbance at 340 nm, which reflects the NADH
